Evidence map›Paper›PMID 17486071›Full record

ArticleOncogene2007

p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing.

M B Flinterman, J S Mymryk, P Klanrit, A F Yousef, S W Lowe, C Caldas, J Gäken, F Farzaneh, M Tavassoli

Abstract read
In one paragraph

Article in Oncogene, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 26 citations in OpenAlex.

  1. Chromatin Modifier EP400 Regulates Oocyte Quality and Zygotic Genome Activation in Mice.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
  2. Prognostic Significance ofInternational journal of molecular sciences · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  10. Improved potency and selectivity of an oncolytic E1ACR2 and E1B19K deleted adenoviral mutant in prostate and pancreatic cancers.Clinical cancer research : an official journal of the American Association for Cancer Research · 2010
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

M B FlintermanHead and Neck Oncology Group, King's College London, London, UK.
J S Mymryk
P Klanrit
A F Yousef
S W Lowe
C Caldas
J Gäken
F Farzaneh
M Tavassoli
King's College London · GBWestern University · CACold Spring Harbor Laboratory · USUniversity of Cambridge · GB

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
VIRAL TRANSACTIVATIONP01CA013106 · NCI · COLD SPRING HARBOR LABORATORY · PI Camila dos Santos · 1985 to 2026
$116.8M
NCI NIH HHS P01 CA013106NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

We have recently shown that E1A protein of human adenovirus downregulates epidermal growth factor receptor (EGFR) expression and induces apoptosis in head and neck (HNSCC) and lung cancer cells independently of their p53 status. E1A has five isoforms of which the major ones E1A12S and E1A13S regulate transcription of cellular genes by binding to transcriptional modulators such as pRB, CtBP, p300 and p400. In this study, we have identified E1A12S isoform to have the highest effect on EGFR suppression and induction of apoptosis in HNSCC cells. Similar to Ad5, E1A12S from human adenovirus types 2, 3, 9 and 12 suppressed EGFR, whereas E1A12S of adenovirus types 4 and 40 had no effect on EGFR expression. Using deletion mutants of E1A12S we have shown that interaction of E1A with p400, but not p300 or pRB, is required for EGFR suppression and apoptosis. Inhibition of p400 by short hairpin RNA confirmed that HNSCC cells with reduced p400 expression were less sensitive to E1A-induced suppression of EGFR and apoptosis. p300 function was shown to be dispensable, as cells expressing E1A mutants that are unable to bind p300, or p300 knockout cells, remained sensitive to E1A-induced apoptosis. In summary, this study identifies p400 as an important mediator of E1A-induced downregulation of EGFR and apoptosis.

Indexed as

ApoptosisAdenovirus E1A ProteinsAdenoviruses, HumanBlotting, WesternCarcinoma, Squamous CellCell ProliferationColonic NeoplasmsDNA-Binding ProteinsDNA HelicasesE1A-Associated p300 ProteinErbB ReceptorsGene Expression RegulationHead and Neck NeoplasmsHumansLung NeoplasmsProtein IsoformsAdenovirus E1A ProteinsDNA-Binding ProteinsDNA HelicasesE1A-Associated p300 ProteinEP300 protein, humanEP400 protein, humanErbB ReceptorsProtein IsoformsRetinoblastoma ProteinRNA, MessengerTumor Suppressor Protein p53

Identifiers

PMID17486071
PMCPMC4591001
OpenAlexW1979299534

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.